ArticleRSC advances2026
Environmentally friendly fluorescence platform for detection of tetracycline in pharmaceutical formulations and human serums based on highly fluorescent 1,4-di-2-(5-phenyloxazolyl)-benzene.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tetracycline (TC) is an efficient antibiotic used for curing different bacterial infections in both humans and animals. Accurate and precise detection of TC is a requisite for quality control of pharmaceutical productions and patient safety using a reliable method. This study presents a highly sensitive and selective strategy based on utilizing 1,4-di-2-(5-phenyloxazolyl)-benzene (POB) as a molecular fluorescence sensor for detecting TC. POB displays an optimal excitation and a high-intensity emission at 355 nm and 418 nm, respectively. The TC-POB interaction leads to a remarkable quenching of the fluorescence, allowing fluorometric detection of TC. A linear calibration curve in a range of 0.5-40 µM along with a limit of detection (LOD) of 0.143 µM was established. The analytical applicability of the developed method was estimated for measuring TC within pharmaceutical formulations and human serum samples, revealing high accuracy and precision. Ultimately, the greenness of the proposed method was inspected
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.